Effectiveness of influenza vaccines in preventing severe influenza illness among adults: a systematic review and meta-analysis of test-negative design case-control …

M Rondy, N El Omeiri, MG Thompson, A Levêque… - Journal of Infection, 2017 - Elsevier
Objectives Summary evidence of influenza vaccine effectiveness (IVE) against hospitalized
influenza is lacking. We conducted a meta-analysis of studies reporting IVE against …

Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or …

C Carter, KV Houser, GV Yamshchikov, AR Bellamy… - PLoS …, 2019 - journals.plos.org
Background Seasonal influenza results in significant morbidity and mortality worldwide, but
the currently licensed inactivated vaccines generally have low vaccine efficacies and could …

[HTML][HTML] Importance and value of adjuvanted influenza vaccine in the care of older adults from a European perspective–A systematic review of recently published …

BC Gärtner, T Weinke, K Wahle, A Kwetkat, D Beier… - Vaccine, 2022 - Elsevier
Background There is an urgent need for improved influenza vaccines especially for older
adults due to the presence of immunosenescence. It is therefore highly relevant to compare …

A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly …

C Hatz, JP Cramer, A Vertruyen, TF Schwarz… - Vaccine, 2012 - Elsevier
BACKGROUND: Modern cell-culture production techniques and the use of adjuvants helps
to ensure that the global demand for pandemic influenza vaccine can be met. This study …

The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review

BB Lindsey, EP Armitage, B Kampmann… - The Lancet Infectious …, 2019 - thelancet.com
The burden of influenza in Africa is substantial and underappreciated. Although surveillance
has increased, the medical community's understanding of seasonal influenza vaccine …

Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted …

HJ Cheong, JY Song, JY Heo, JY Noh… - Clinical and Vaccine …, 2011 - Am Soc Microbiol
Since initial reports in April 2009, the pandemic influenza A (H1N1) virus has spread
globally. Influenza vaccines are the primary method for the control of influenza and its …

[PDF][PDF] Pharmacoeconomic evaluation of the MF59-adjuvanted influenza vaccine in the elderly population in Italy

S Iannazzo - J Prev Med Hyg, 2011 - core.ac.uk
Introduction. Influenza vaccination has proven effective in the reduction of influenza-like
illness (ILI) cases and influenza-related hospitalizations, drug consumption, primary care …

Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses

L Manzoli, JPA Ioannidis, ME Flacco… - Human vaccines & …, 2012 - Taylor & Francis
Fifteen meta-analyses have been published between 1995 and 2011 to evaluate the
efficacy/effectiveness and harms of diverse influenza vaccines—seasonal, H5N1 and 2009 …

Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis

K Wilkinson, Y Wei, A Szwajcer, R Rabbani… - Vaccine, 2017 - Elsevier
Introduction Older adults are prioritized for influenza vaccination but also have lowered
antibody responses to the vaccine. Higher-doses of influenza antigen may increase immune …

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the …

Z Vajo, F Tamas, L Sinka, I Jankovics - The Lancet, 2010 - thelancet.com
Background With the ongoing 2009 pandemic of influenza A H1N1, development of
pandemic influenza vaccines has generated much interest. We investigated the safety and …